(GRTX) – Hot FDA News
-
Galera Therapeutics (GRTX) says FDA reiterated need for additional Phase 3 trial of avasopasem manganese for radiotherapy-induced SOM
-
Galera Therapeutics (GRTX) Receives CRL from U.S. FDA for Avasopasem Manganese
-
-
-
Back to GRTX Stock Lookup